Frankie L. Stinson

Array ( [id] => 6026930 [patent_doc_number] => 20110054166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'ACYLATED PHTHALOCYANINES' [patent_app_type] => utility [patent_app_number] => 12/862794 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3626 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054166.pdf [firstpage_image] =>[orig_patent_app_number] => 12862794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7967169 [patent_doc_number] => 07939656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Geometric synthesis of porphyrin rods' [patent_app_type] => utility [patent_app_number] => 12/856020 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19941 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939656.pdf [firstpage_image] =>[orig_patent_app_number] => 12856020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313828 [patent_doc_number] => 20120190849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'PROCESSES FOR THE PREPARATION OF VARDENAFIL' [patent_app_type] => utility [patent_app_number] => 13/389358 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4733 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503633 [patent_doc_number] => 08741947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Biologically active macrolides, compositions, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/851691 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26505 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12851691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9232873 [patent_doc_number] => 08598177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-03 [patent_title] => 'Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments' [patent_app_type] => utility [patent_app_number] => 12/851198 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16090 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12851198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290351 [patent_doc_number] => 20120178678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'DERIVATIVES OF 2H PYRIDAZIN- 3 -ONES, THEIR PREPARATION AND THEIR USE AS SCD-1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/388884 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28553 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929872 [patent_doc_number] => 20110039831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => '3-HETEROARYLMETHYL-IMIDAZO[1,2-B]PYRIDAZIN-6-YL DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/849642 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33052 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039831.pdf [firstpage_image] =>[orig_patent_app_number] => 12849642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140353 [patent_doc_number] => 08580813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals' [patent_app_type] => utility [patent_app_number] => 12/845324 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49022 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12845324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149926 [patent_doc_number] => 20110021521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/843702 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60634 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021521.pdf [firstpage_image] =>[orig_patent_app_number] => 12843702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149926 [patent_doc_number] => 20110021521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/843702 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60634 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021521.pdf [firstpage_image] =>[orig_patent_app_number] => 12843702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149926 [patent_doc_number] => 20110021521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/843702 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60634 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021521.pdf [firstpage_image] =>[orig_patent_app_number] => 12843702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149926 [patent_doc_number] => 20110021521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/843702 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60634 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021521.pdf [firstpage_image] =>[orig_patent_app_number] => 12843702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199472 [patent_doc_number] => 20120122903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => '1-H-QUINAZOLINE-2, 4-DIONES FOR USE IN THE TREATMENT OF NEURONAL CEROID LIPOFUSCINOSIS' [patent_app_type] => utility [patent_app_number] => 13/384280 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7704 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122903.pdf [firstpage_image] =>[orig_patent_app_number] => 13384280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432209 [patent_doc_number] => 07968555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Intermediates in the preparation of entecavir via carbon-silicon oxidation' [patent_app_type] => utility [patent_app_number] => 12/841669 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12631 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968555.pdf [firstpage_image] =>[orig_patent_app_number] => 12841669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177677 [patent_doc_number] => 20110178066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Hydroxypiperidine derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/804449 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11461 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178066.pdf [firstpage_image] =>[orig_patent_app_number] => 12804449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253144 [patent_doc_number] => 20120157464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'USE OF AZABICYCLOALKYL DERIVATIVES OR PYRROLIDINE-2-ONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF ATAXIA' [patent_app_type] => utility [patent_app_number] => 13/383690 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7541 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157464.pdf [firstpage_image] =>[orig_patent_app_number] => 13383690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982140 [patent_doc_number] => 08513253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors' [patent_app_type] => utility [patent_app_number] => 12/840612 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75901 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12840612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401505 [patent_doc_number] => 20100305083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'SUBSTITUTED PORPHYRINS' [patent_app_type] => utility [patent_app_number] => 12/836969 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12444 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305083.pdf [firstpage_image] =>[orig_patent_app_number] => 12836969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6450593 [patent_doc_number] => 20100280237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PREPARATION OF METAL MESOPORPHYRIN COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/833873 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7873 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280237.pdf [firstpage_image] =>[orig_patent_app_number] => 12833873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186566 [patent_doc_number] => 20110124650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'STABLE CRYSTALLINE SALTS OF ANTIFOLATE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/831617 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17845 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124650.pdf [firstpage_image] =>[orig_patent_app_number] => 12831617 [rel_patent_id] =>[rel_patent_doc_number] =>)